C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/62 (2006.01) A61K 39/245 (2006.01) C07K 14/05 (2006.01) C07K 19/00 (2006.01) C12N 15/38 (2006.01) G01N 33/569 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2596929
The invention relates to immunogenic peptides from EBV type I and II latency antigens, comprising at least one T CD4+ epitope which can be recognised by the majority of individuals in the Caucasian population. The invention also relates to the diagnostic and therapeutic applications of same.
Peptides immunogènes issus des antigènes de latence de type I et II d'EBV comprenant au moins un épitope T CD4+ apte ô être reconnu par la majorité des individus de la population caucasienne, et leurs applications diagnostiques et thérapeutiques.
Auriault Claude
Depil Stephane
Maillere Bernard
Morales Olivier
Munier Gaetan
Centre National de La Recherche Scientifique
Universite de Lille 2
LandOfFree
T cd4+ epitopes of type i and ii latency antigens of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with T cd4+ epitopes of type i and ii latency antigens of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and T cd4+ epitopes of type i and ii latency antigens of the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1829295